FDA approval of PATHWAY HER2 (4B5) test expands diagnostic capabilities for HER2-ultralow metastatic breast cancer, enabling targeted treatment with trastuzumab deruxtecan. HER2-ultralow ...
Generative AI has radically transformed digital creation. AI image generators can produce pictures from just a few words in a prompt, and it's becoming easier than ever to find and use these programs.
Seagen is a specialist in antibody-drug conjugates, but has looked to Chinese biotech RemeGen for a HER2-targeting candidate that could challenge rival drugs from AstraZeneca/Daiichi Sankyo and Roche.
Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...
We torture-test a dozen of the most popular text-to-image AI tools with a series of prompts designed to highlight their strengths and weaknesses. Here's how they stack up. I've been writing about ...
According to the Kruskal–Wallis test, the association between MSN expression and histological grade, ER/PR status, HER2 status, lymph node metastasis, AJCC stage, and age at diagnosis was also ...
Breast cancer is one of the most frequent cancer types worldwide and the first cause of cancer-related deaths in women. Although significant therapeutic advances have been achieved with drugs such as ...
The challenges that have arisen haven’t rewritten the PR manual, but they have made the principle of positive image that much more difficult to apply. This isn’t only because of politics, as an ...
A MUM has shared a shocking photo of a giant lump protruding from her breast, which doctors repeatedly dismissed a benign. But after months of being told there was nothing to worry about, Tirzah ...